MicroMediome Signs MOU with Vakona AB (Sweden) for Protein-Based Cosmetic Technology

SEOUL, South Korea  — MicroMediome is pleased to announce the signing of a Memorandum of Understanding (MOU) with Vakona AB, a biotechnology company based in Umeå, Sweden. This partnership aims to evaluate the integration of advanced protein solutions into next-generation cosmetic formulations.

Through this collaboration, both companies will conduct joint Proof of Concept (PoC) research. Key areas of focus include:

• Formulation Compatibility: Assessing how Vakona’s protein-based materials interact with MicroMediOm’s proprietary bases.

• Stability Testing: Ensuring long-term efficacy and safety of the combined ingredients.

• Commercial Viability: Analyzing the potential for large-scale production and market entry.

"This collaboration marks an exploratory phase in our mission to redefine bio-cosmetics. Upon successful research results, we look forward to discussing long-term partnerships, including joint development and licensing agreements."

MicroMediome remains committed to leading the Next-Generation Bio-Cosmetic market by leveraging our microbial healthcare expertise and expanding our global strategic network.